Loading...

Parkash Singh Gill, MD

Title(s)Professor of Medicine
Address1441 Eastlake Ave.
Health Sciences Campus
Los Angeles CA 90033
Phone+1 323 865 3909
vCardDownload vCard
    Other Positions
    Title(s)Renette and Marshall Ezralow Family Chair in Cancer Therapeutics


    Collapse Overview 
    Collapse Overview
    Dr. Gill's primary research interest is in studying novel targets that are expressed both in tumor blood vessels as well as the tumor cell. He has demonstrated the ability to identify and validate novel targets, develop novel target therapeutics and collaborate with clinical investigators to conduct early stage clinical trials.

    Dr. Gill has a strong history of clinical investigations and drug development. His clinical investigations led to the approval of three cancer drugs by the FDA. He also served on the advisory panel for the FDA advisory committee on biologics. Over the past several years his work has focused on the identification of novel cancer and cancer blood vessel targets, validation of the targets in various model systems including genetic mouse models.

    Collapse Research 
    Collapse Research Activities and Funding
    VEGFs in Artery-Vein Imbalance in AIDS-Kaposi Sarcoma
    NIH/NCI R01CA079218Jun 1, 1999 - Mar 31, 2010
    Role: Principal Investigator
    ANGIOGENIC FACTORS AND THEIR EXPRESSION/REGULATION IN KS
    NIH/NHLBI R01HL048499May 1, 1992 - Jan 31, 1996
    Role: Principal Investigator
    PATHOGENISIS OF KAPOSI'S SARCOMA
    NIH/NCI R01CA051621Sep 30, 1989 - Jul 31, 1995
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse In The News
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Delta-like ligand 4-mediated Notch signaling controls proliferation of second heart field progenitor cells by regulating Fgf8 expression. Development. 2020 Sep 11; 147(17). De Zoysa P, Liu J, Toubat O, Choi J, Moon A, Gill PS, Duarte A, Sucov HM, Kumar SR. PMID: 32778568.
      View in: PubMed   Mentions:    Fields:    
    2. Tetraspanin18 regulates angiogenesis through VEGFR2 and Notch pathways. Biol Open. 2020 Jul 21. Li GX, Zhang S, Liu R, Singh B, Singh S, Quinn DI, Crump G, Gill PS. PMID: 32694189.
      View in: PubMed   Mentions:
    3. Reply by Authors. J Urol. 2020 10; 204(4):660. Cacciamani GE, Ghodoussipour S, Mari A, Gill KS, Desai M, Artibani W, Gill PS, Shariat SF, Gill IS, Djaladat H. PMID: 32648804.
      View in: PubMed   Mentions:    Fields:    
    4. EphrinB2 expression in prostate adenocarcinoma: Implications for targeted therapy. Pathol Res Pract. 2020 Jun; 216(6):152967. Gupta C, Sali A, Ma B, Jackovich A, Sadeghi S, Quinn D, Gill P, Gill I. PMID: 32362422.
      View in: PubMed   Mentions:    Fields:    
    5. Association between Smoking Exposure, Neoadjuvant Chemotherapy Response and Survival Outcomes following Radical Cystectomy: Systematic Review and Meta-Analysis. J Urol. 2020 10; 204(4):649-660. Cacciamani GE, Ghodoussipour S, Mari A, Gill KS, Desai M, Artibani W, Gill PS, Shariat SF, Gill IS, Djaladat H. PMID: 32105187.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Programmed Death 1 and Programmed Death Ligand 1 Inhibitors in Advanced and Recurrent Urothelial Carcinoma: Meta-analysis of Single-Agent Studies. Clin Genitourin Cancer. 2020 Oct; 18(5):351-360.e3. Tafuri A, Smith DD, Cacciamani GE, Cole S, Shakir A, Sadeghi S, Vogelzang NJ, Quinn D, Gill PS, Gill IS. PMID: 32146152.
      View in: PubMed   Mentions:    Fields:    
    7. EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cells. Cell Death Dis. 2019 10 22; 10(11):801. Sagar V, Vatapalli R, Lysy B, Pamarthy S, Anker JF, Rodriguez Y, Han H, Unno K, Stadler WM, Catalona WJ, Hussain M, Gill PS, Abdulkadir SA. PMID: 31641103.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    8. GRP78 regulates CD44v membrane homeostasis and cell spreading in tamoxifen-resistant breast cancer. Life Sci Alliance. 2019 08; 2(4). Tseng CC, Stanciauskas R, Zhang P, Woo D, Wu K, Kelly K, Gill PS, Yu M, Pinaud F, Lee AS. PMID: 31416894.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    9. Histological Validation of 11Carbon-Acetate Positron Emission Tomography/Computerized Tomography in Detecting Lymph Node Metastases in Prostate Cancer. J Urol. 2019 02; 201(2):332-341. Rajarubendra N, Almeida F, Manojlovic Z, Ohe C, Ahmadi N, Cacciamani G, Qiu M, Abreu A, Cai J, Miranda G, Stern MC, Carpten J, Kuhn P, Amin MB, Gill PS, Aron M, Gill IS. PMID: 30218760.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Correction: AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2018 Dec 01; 24(23):6099. Brand TM, Iida M, Stein AP, Corrigan KL, Braverman CM, Coan JP, Pearson HE, Bahrar H, Fowler TL, Bednarz BP, Saha S, Yang D, Gill PS, Lingen MW, Saloura V, Villaflor VM, Salgia R, Kimple RJ, Wheeler DL. PMID: 30510088.
      View in: PubMed   Mentions:    Fields:    
    11. EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT. Blood Adv. 2017 Sep 12; 1(20):1635-1644. Merchant AA, Jorapur A, McManus A, Liu R, Krasnoperov V, Chaudhry P, Singh M, Harton L, Agajanian M, Kim M, Triche TJ, Druker BJ, Tyner JW, Gill PS. PMID: 29296810.
      View in: PubMed   Mentions: 4     Fields:    
    12. GRP78 haploinsufficiency suppresses acinar-to-ductal metaplasia, signaling, and mutant Kras-driven pancreatic tumorigenesis in mice. Proc Natl Acad Sci U S A. 2017 05 16; 114(20):E4020-E4029. Shen J, Ha DP, Zhu G, Rangel DF, Kobielak A, Gill PS, Groshen S, Dubeau L, Lee AS. PMID: 28461470.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    13. Robotic salvage retroperitoneal and pelvic lymph node dissection for 'node-only' recurrent prostate cancer: technique and initial series. BJU Int. 2017 09; 120(3):401-408. Abreu A, Fay C, Park D, Quinn D, Dorff T, Carpten J, Kuhn P, Gill P, Almeida F, Gill I. PMID: 27981731.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Identifying aggressive prostate cancer foci using a DNA methylation classifier. Genome Biol. 2017 01 12; 18(1):3. Mundbjerg K, Chopra S, Alemozaffar M, Duymich C, Lakshminarasimhan R, Nichols PW, Aron M, Siegmund KD, Ukimura O, Aron M, Stern M, Gill P, Carpten JD, Ørntoft TF, Sørensen KD, Weisenberger DJ, Jones PA, Duddalwar V, Gill I, Liang G. PMID: 28081708.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    15. Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas. Sci Rep. 2016 12 12; 6:38792. Bhatia S, Hirsch K, Sharma J, Oweida A, Griego A, Keysar S, Jimeno A, Raben D, Krasnoperov V, Gill PS, Pasquale EB, Wang XJ, Karam SD. PMID: 27941840.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    16. Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways. Oncotarget. 2015 Oct 06; 6(30):29143-60. Wu X, Zahari MS, Ma B, Liu R, Renuse S, Sahasrabuddhe NA, Chen L, Chaerkady R, Kim MS, Zhong J, Jelinek C, Barbhuiya MA, Leal-Rojas P, Yang Y, Kashyap MK, Marimuthu A, Ling M, Fackler MJ, Merino V, Zhang Z, Zahnow CA, Gabrielson E, Stearns V, Roa JC, Sukumar S, Gill PS, Pandey A. PMID: 26356563.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    17. PET Imaging of Dll4 Expression in Glioblastoma and Colorectal Cancer Xenografts Using (64)Cu-Labeled Monoclonal Antibody 61B. Mol Pharm. 2015 Oct 05; 12(10):3527-34. Zhou B, Wang H, Liu R, Wang M, Deng H, Giglio BC, Gill PS, Shan H, Li Z. PMID: 26288060.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    18. Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma. Br J Cancer. 2015 Aug 11; 113(4):616-25. Yu H, Liu R, Ma B, Li X, Yen HY, Zhou Y, Krasnoperov V, Xia Z, Zhang X, Bove AM, Buscarini M, Parekh D, Gill IS, Liao Q, Tretiakova M, Quinn D, Zhao J, Gill PS. PMID: 26180925.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    19. Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer. Sci Rep. 2015 Jun 15; 5:10641. Ferguson BD, Carol Tan YH, Kanteti RS, Liu R, Gayed MJ, Vokes EE, Ferguson MK, John Iafrate A, Gill PS, Salgia R. PMID: 26073592.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    20. Small-Animal PET Imaging of Pancreatic Cancer Xenografts Using a 64Cu-Labeled Monoclonal Antibody, MAb159. J Nucl Med. 2015 Jun; 56(6):908-13. Wang H, Li D, Liu S, Liu R, Yuan H, Krasnoperov V, Shan H, Conti PS, Gill PS, Li Z. PMID: 25908833.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    21. AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2015 Jun 01; 21(11):2601-12. Brand TM, Iida M, Stein AP, Corrigan KL, Braverman CM, Coan JP, Pearson HE, Bahrar H, Fowler TL, Bednarz BP, Saha S, Yang D, Gill PS, Lingen MW, Saloura V, Villaflor VM, Salgia R, Kimple RJ, Wheeler DL. PMID: 25767293.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    22. Targeting the glucose-regulated protein-78 abrogates Pten-null driven AKT activation and endometrioid tumorigenesis. Oncogene. 2015 Oct; 34(43):5418-26. Lin YG, Shen J, Yoo E, Liu R, Yen HY, Mehta A, Rajaei A, Yang W, Mhawech-Fauceglia P, DeMayo FJ, Lydon J, Gill P, Lee AS. PMID: 25684138.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    23. Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibition. Growth Factors. 2014 Dec; 32(6):202-6. Ferguson BD, Tretiakova MS, Lingen MW, Gill PS, Salgia R. PMID: 25391996.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    24. The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder. PLoS One. 2014; 9(8):e105326. Li X, Choi WW, Yan R, Yu H, Krasnoperov V, Kumar SR, Schuckman A, Klumpp DJ, Pan CX, Quinn D, Gill IS, Gill PS, Liu R. PMID: 25148033.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    25. AXL mediates resistance to cetuximab therapy. Cancer Res. 2014 Sep 15; 74(18):5152-64. Brand TM, Iida M, Stein AP, Corrigan KL, Braverman CM, Luthar N, Toulany M, Gill PS, Salgia R, Kimple RJ, Wheeler DL. PMID: 25136066.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimalsCells
    26. Axl-targeted cancer imaging with humanized antibody h173. Mol Imaging Biol. 2014 Aug; 16(4):511-8. Li D, Liu S, Liu R, Park R, Yu H, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. PMID: 24424460.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    27. Design, synthesis, and validation of Axl-targeted monoclonal antibody probe for microPET imaging in human lung cancer xenograft. Mol Pharm. 2014 Nov 03; 11(11):3974-9. Liu S, Li D, Guo J, Canale N, Li X, Liu R, Krasnoperov V, Gill PS, Conti PS, Shan H, Li Z. PMID: 24978094.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    28. EphB4-targeted imaging with antibody h131, h131-F(ab')2 and h131-Fab. Mol Pharm. 2013 Dec 02; 10(12):4527-33. Li D, Liu S, Liu R, Zhou Y, Park R, Naga K, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. PMID: 24147882.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    29. Monoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis. Clin Cancer Res. 2013 Dec 15; 19(24):6802-11. Liu R, Li X, Gao W, Zhou Y, Wey S, Mitra SK, Krasnoperov V, Dong D, Liu S, Li D, Zhu G, Louie S, Conti PS, Li Z, Lee AS, Gill PS. PMID: 24048331.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansAnimalsCells
    30. The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target. PLoS One. 2013; 8(7):e67668. Ferguson BD, Liu R, Rolle CE, Tan YH, Krasnoperov V, Kanteti R, Tretiakova MS, Cervantes GM, Hasina R, Hseu RD, Iafrate AJ, Karrison T, Ferguson MK, Husain AN, Faoro L, Vokes EE, Gill PS, Salgia R. PMID: 23844053.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    31. EphB4 as a therapeutic target in mesothelioma. BMC Cancer. 2013 May 30; 13:269. Liu R, Ferguson BD, Zhou Y, Naga K, Salgia R, Gill PS, Krasnoperov V. PMID: 23721559.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    32. PET imaging of colorectal and breast cancer by targeting EphB4 receptor with 64Cu-labeled hAb47 and hAb131 antibodies. J Nucl Med. 2013 Jul; 54(7):1094-100. Liu S, Li D, Park R, Liu R, Xia Z, Guo J, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. PMID: 23667241.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    33. Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring. Mol Pharm. 2013 Jan 07; 10(1):329-36. Li D, Liu S, Liu R, Park R, Hughes L, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. PMID: 23211050.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    34. Low-dosage inhibition of Dll4 signaling promotes wound healing by inducing functional neo-angiogenesis. PLoS One. 2012; 7(1):e29863. Trindade A, Djokovic D, Gigante J, Badenes M, Pedrosa AR, Fernandes AC, Lopes-da-Costa L, Krasnoperov V, Liu R, Gill PS, Duarte A. PMID: 22279550.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    35. Inhibition of Notch signaling by Dll4-Fc promotes reperfusion of acutely ischemic tissues. Biochem Biophys Res Commun. 2012 Feb 03; 418(1):173-9. Liu R, Trindade A, Sun Z, Kumar R, Weaver FA, Krasnoperov V, Naga K, Duarte A, Gill PS. PMID: 22252294.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    36. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis. BMC Cancer. 2010 Nov 23; 10:641. Djokovic D, Trindade A, Gigante J, Badenes M, Silva L, Liu R, Li X, Gong M, Krasnoperov V, Gill PS, Duarte A. PMID: 21092311.
      View in: PubMed   Mentions: 42     Fields:    Translation:AnimalsCells
    37. Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice. . 2010 Nov 15; 10(10):1033-40. Ahmad A, Groshong JS, Matta H, Schamus S, Punj V, Robinson LJ, Gill PS, Chaudhary PM. PMID: 20818173.
      View in: PubMed   Mentions:
    38. Ocular safety profile and intraocular pharmacokinetics of an antagonist of EphB4/EphrinB2 signalling. Br J Ophthalmol. 2010 Dec; 94(12):1668-73. Brar M, Cheng L, Yuson R, Mojana F, Freeman WR, Gill PS. PMID: 20934994.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    39. Immune evasion by Kaposi's sarcoma-associated herpesvirus. Future Microbiol. 2010 Sep; 5(9):1349-65. Lee HR, Lee S, Chaudhary PM, Gill P, Jung JU. PMID: 20860481.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    40. Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinoma. . 2010 Aug; 9(8):2377-88. Spannuth WA, Mangala LS, Stone RL, Carroll AR, Nishimura M, Shahzad MM, Lee SJ, Moreno-Smith M, Nick AM, Liu R, Jennings NB, Lin YG, Merritt WM, Coleman RL, Vivas-Mejia PE, Zhou Y, Krasnoperov V, Lopez-Berestein G, Gill PS, Sood AK. PMID: 20682653.
      View in: PubMed   Mentions:
    41. Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma. Blood. 2010 Jul 15; 116(2):297-305. Liu R, Gong M, Li X, Zhou Y, Gao W, Tulpule A, Chaudhary PM, Jung J, Gill PS. PMID: 20442363.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    42. Cell surface relocalization of the endoplasmic reticulum chaperone and unfolded protein response regulator GRP78/BiP. J Biol Chem. 2010 May 14; 285(20):15065-75. Zhang Y, Liu R, Ni M, Gill P, Lee AS. PMID: 20208072.
      View in: PubMed   Mentions: 102     Fields:    Translation:HumansCells
    43. Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth. Am J Pathol. 2010 Apr; 176(4):2029-38. Krasnoperov V, Kumar SR, Ley E, Li X, Scehnet J, Liu R, Zozulya S, Gill PS. PMID: 20133814.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    44. KSHV-induced notch components render endothelial and mural cell characteristics and cell survival. Blood. 2010 Jan 28; 115(4):887-95. Liu R, Li X, Tulpule A, Zhou Y, Scehnet JS, Zhang S, Lee JS, Chaudhary PM, Jung J, Gill PS. PMID: 19965636.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    45. Soluble EphB4 inhibition of PDGF-induced RPE migration in vitro. Invest Ophthalmol Vis Sci. 2010 Jan; 51(1):543-52. He S, Kumar SR, Zhou P, Krasnoperov V, Ryan SJ, Gill PS, Hinton DR. PMID: 19696168.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    46. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Res. 2009 May 01; 69(9):3736-45. Kumar SR, Scehnet JS, Ley EJ, Singh J, Krasnoperov V, Liu R, Manchanda PK, Ladner RD, Hawes D, Weaver FA, Beart RW, Singh G, Nguyen C, Kahn M, Gill PS. PMID: 19366806.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansAnimalsCells
    47. Loss of Notch signalling induced by Dll4 causes arterial calibre reduction by increasing endothelial cell response to angiogenic stimuli. BMC Dev Biol. 2008 Dec 16; 8:117. Benedito R, Trindade A, Hirashima M, Henrique D, da Costa LL, Rossant J, Gill PS, Duarte A. PMID: 19087347.
      View in: PubMed   Mentions: 25     Fields:    Translation:AnimalsCells
    48. The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade. Blood. 2009 Jan 01; 113(1):254-63. Scehnet JS, Ley EJ, Krasnoperov V, Liu R, Manchanda PK, Sjoberg E, Kostecke AP, Gupta S, Kumar SR, Gill PS. PMID: 18836096.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    49. The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2008 Sep; 134(9):985-91. Yavrouian EJ, Sinha UK, Rice DH, Salam MT, Gill PS, Masood R. PMID: 18794445.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    50. Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos. Blood. 2008 Sep 01; 112(5):1720-9. Trindade A, Kumar SR, Scehnet JS, Lopes-da-Costa L, Becker J, Jiang W, Liu R, Gill PS, Duarte A. PMID: 18559979.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimalsCells
    51. Interleukin-2, interleukin-12, and interferon-gamma levels and risk of young adult Hodgkin lymphoma. Blood. 2008 Apr 01; 111(7):3377-82. Cozen W, Gill PS, Salam MT, Nieters A, Masood R, Cockburn MG, Gauderman WJ, Martínez-Maza O, Nathwani BN, Pike MC, Van Den Berg DJ, Hamilton AS, Deapen DM, Mack TM. PMID: 18077789.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    52. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer. Mol Cancer Res. 2007 Apr; 5(4):351-62. Ku TK, Nguyen DC, Karaman M, Gill P, Hacia JG, Crowe DL. PMID: 17426250.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    53. The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome. Br J Cancer. 2007 Apr 10; 96(7):1083-91. Kumar SR, Masood R, Spannuth WA, Singh J, Scehnet J, Kleiber G, Jennings N, Deavers M, Krasnoperov V, Dubeau L, Weaver FA, Sood AK, Gill PS. PMID: 17353927.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
    54. Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood. 2007 Jun 01; 109(11):4753-60. Scehnet JS, Jiang W, Kumar SR, Krasnoperov V, Trindade A, Benedito R, Djokovic D, Borges C, Ley EJ, Duarte A, Gill PS. PMID: 17311993.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansAnimalsCells
    55. Framework shuffling of antibodies to reduce immunogenicity and manipulate functional and biophysical properties. Mol Immunol. 2007 Apr; 44(11):3049-60. Damschroder MM, Widjaja L, Gill PS, Krasnoperov V, Jiang W, Dall'Acqua WF, Wu H. PMID: 17241664.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    56. The association between elevated EphB4 expression, smoking status, and advanced-stage disease in patients with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006 Oct; 132(10):1053-9. Sinha UK, Mazhar K, Chinn SB, Dhillon VK, Liu L, Masood R, Rice DH, Gill PS. PMID: 17043250.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    57. EphB4 provides survival advantage to squamous cell carcinoma of the head and neck. Int J Cancer. 2006 Sep 15; 119(6):1236-48. Masood R, Kumar SR, Sinha UK, Crowe DL, Krasnoperov V, Reddy RK, Zozulya S, Singh J, Xia G, Broek D, Schönthal AH, Gill PS. PMID: 16615113.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    58. Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol. 2006 Jul; 169(1):279-93. Kumar SR, Singh J, Xia G, Krasnoperov V, Hassanieh L, Ley EJ, Scehnet J, Kumar NG, Hawes D, Press MF, Weaver FA, Gill PS. PMID: 16816380.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansAnimalsCells
    59. Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer. J Urol. 2006 Apr; 175(4):1245-52. Xia G, Kumar SR, Hawes D, Cai J, Hassanieh L, Groshen S, Zhu S, Masood R, Quinn DI, Broek D, Stein JP, Gill PS. PMID: 16515971.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    60. Phase I study of antisense oligonucleotide against vascular endothelial growth factor: decrease in plasma vascular endothelial growth factor with potential clinical efficacy. J Clin Oncol. 2006 Apr 10; 24(11):1712-9. Levine AM, Tulpule A, Quinn DI, Gorospe G, Smith DL, Hornor L, Boswell WD, Espina BM, Groshen SG, Masood R, Gill PS. PMID: 16520466.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    61. EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival. Oncogene. 2006 Feb 02; 25(5):769-80. Xia G, Kumar SR, Stein JP, Singh J, Krasnoperov V, Zhu S, Hassanieh L, Smith DL, Buscarini M, Broek D, Quinn DI, Weaver FA, Gill PS. PMID: 16205642.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    62. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization. Invest Ophthalmol Vis Sci. 2005 Dec; 46(12):4772-9. He S, Ding Y, Zhou J, Krasnoperov V, Zozulya S, Kumar SR, Ryan SJ, Gill PS, Hinton DR. PMID: 16303978.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    63. The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth. Blood. 2006 Mar 15; 107(6):2330-8. Kertesz N, Krasnoperov V, Reddy R, Leshanski L, Kumar SR, Zozulya S, Gill PS. PMID: 16322467.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimalsCells
    64. Up-regulation of EphB4 in mesothelioma and its biological significance. Clin Cancer Res. 2005 Jun 15; 11(12):4305-15. Xia G, Kumar SR, Masood R, Koss M, Templeman C, Quinn D, Zhu S, Reddy R, Krasnoperov V, Gill PS. PMID: 15958611.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    65. EphB4 expression and biological significance in prostate cancer. Cancer Res. 2005 Jun 01; 65(11):4623-32. Xia G, Kumar SR, Masood R, Zhu S, Reddy R, Krasnoperov V, Quinn DI, Henshall SM, Sutherland RL, Pinski JK, Daneshmand S, Buscarini M, Stein JP, Zhong C, Broek D, Roy-Burman P, Gill PS. PMID: 15930280.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimalsCells
    66. Molecular prognostic factors in bladder cancer. BJU Int. 2005 Apr; 95(6):739-42. Buscarini M, Quek ML, Gill P, Xia G, Quinn DI, Stein JP. PMID: 15794774.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    67. VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer. Surgery. 2005 Feb; 137(2):192-9. Hotz HG, Hines OJ, Masood R, Hotz B, Foitzik T, Buhr HJ, Gill PS, Reber HA. PMID: 15674201.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    68. Th1 and Th2 cytokines and IgE levels in identical twins with varying levels of cigarette consumption. J Clin Immunol. 2004 Nov; 24(6):617-22. Cozen W, Diaz-Sanchez D, James Gauderman W, Zadnick J, Cockburn MG, Gill PS, Masood R, Hamilton AS, Jyrala M, Mack TM. PMID: 15622446.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    69. Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium. Blood. 2005 Feb 01; 105(3):1310-8. Masood R, Xia G, Smith DL, Scalia P, Still JG, Tulpule A, Gill PS. PMID: 15471957.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    70. VEGF and myeloid leukemias. Leuk Res. 2004 Jul; 28(7):675-7. Frankel AE, Gill PS. PMID: 15158088.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    71. IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood. 2004 Apr 15; 103(8):3216-21. Cozen W, Gill PS, Ingles SA, Masood R, Martínez-Maza O, Cockburn MG, Gauderman WJ, Pike MC, Bernstein L, Nathwani BN, Salam MT, Danley KL, Wang W, Gage J, Gundell-Miller S, Mack TM. PMID: 15070705.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    72. Expression of EphB4 in head and neck squamous cell carcinoma. Ear Nose Throat J. 2003 Nov; 82(11):866, 869-70, 887. Sinha UK, Kundra A, Scalia P, Smith DL, Parsa B, Masood R, Gill PS. PMID: 14661437.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    73. Natural killer cell cytolytic activity is necessary for in vivo antitumor activity of the dipeptide L-glutamyl-L-tryptophan. Int J Cancer. 2003 Sep 10; 106(4):528-33. Smith DL, Cai J, Zhu S, Wei W, Fukumoto J, Sharma S, Masood R, Gill PS. PMID: 12845648.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    74. Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops. Int J Cancer. 2003 May 01; 104(5):603-10. Masood R, Kundra A, Zhu S, Xia G, Scalia P, Smith DL, Gill PS. PMID: 12594815.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    75. A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma. Cancer. 2002 Dec 15; 95(12):2555-61. Bernstein ZP, Chanan-Khan A, Miller KC, Northfelt DW, Lopez-Berestein G, Gill PS. PMID: 12467070.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    76. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma. Cancer. 2002 Jul 01; 95(1):147-54. Tulpule A, Groopman J, Saville MW, Harrington W, Friedman-Kien A, Espina BM, Garces C, Mantelle L, Mettinger K, Scadden DT, Gill PS. PMID: 12115328.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    77. Specific targeting of tumor vasculature by diphtheria toxin-vascular endothelial growth factor fusion protein reduces angiogenesis and growth of pancreatic cancer. J Gastrointest Surg. 2002 Mar-Apr; 6(2):159-66; discussion 166. Hotz HG, Gill PS, Masood R, Hotz B, Buhr HJ, Foitzik T, Hines OJ, Reber HA. PMID: 11992800.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    78. Multidrug resistance (MDR-1) expression in AIDS-related lymphomas. Leuk Res. 2002 Feb; 26(2):121-7. Tulpule A, Sherrod A, Dharmapala D, Young LL, Espina BM, Sanchez MN, Gill PS, Levine AM. PMID: 11755462.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    79. Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor. Am J Pathol. 2002 Jan; 160(1):23-9. Masood R, Cesarman E, Smith DL, Gill PS, Flore O. PMID: 11786394.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    80. Retroviral vectors bearing IgG-binding motifs for antibody-mediated targeting of vascular endothelial growth factor receptors. Int J Mol Med. 2001 Oct; 8(4):335-43. Masood R, Gordon EM, Whitley MD, Wu BW, Cannon P, Evans L, Anderson WF, Gill P, Hall FL. PMID: 11562769.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    81. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood. 2001 Sep 15; 98(6):1904-13. Masood R, Cai J, Zheng T, Smith DL, Hinton DR, Gill PS. PMID: 11535528.
      View in: PubMed   Mentions: 89     Fields:    Translation:HumansAnimalsCells
    82. Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma. Clin Cancer Res. 2001 Sep; 7(9):2693-702. Masood R, Cai J, Tulpule A, Zheng T, Hamilton A, Sharma S, Espina BM, Smith DL, Gill PS. PMID: 11555581.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    83. Results of a collaborative study of the EDNAP group regarding the reproducibility and robustness of the Y-chromosome STRs DYS19, DYS389 I and II, DYS390 and DYS393 in a PCR pentaplex format. Forensic Sci Int. 2001 Jun 01; 119(1):28-41. Carracedo A, Beckmann A, Bengs A, Brinkmann B, Caglia A, Capelli C, Gill P, Gusmão L, Hagelberg C, Hohoff C, Hoste B, Kihlgren A, Kloosterman A, Myhre Dupuy B, Morling N, O'Donnell G, Parson W, Phillips C, Pouwels M, Scheithauer R, Schmitter H, Schneider PM, Schumm J, Skitsa I, Stradmann-Bellinghausen B, Stuart M, Syndercombe Court D, Vide C. PMID: 11348791.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    84. Evolving characteristics of AIDS-related lymphoma. Blood. 2000 Dec 15; 96(13):4084-90. Levine AM, Seneviratne L, Espina BM, Wohl AR, Tulpule A, Nathwani BN, Gill PS. PMID: 11110677.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    85. Kaposi sarcoma is a therapeutic target for vitamin D(3) receptor agonist. Blood. 2000 Nov 01; 96(9):3188-94. Masood R, Nagpal S, Zheng T, Cai J, Tulpule A, Smith DL, Gill PS. PMID: 11050002.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    86. Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma. J Clin Oncol. 2000 Feb; 18(4):716-23. Tulpule A, Scadden DT, Espina BM, Cabriales S, Howard W, Shea K, Gill PS. PMID: 10673512.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    87. Paclitaxel Induces Apoptosis in AIDS-Related Kaposi's Sarcoma Cells. Sarcoma. 2000; 4(1-2):37-45. Cai J, Zheng T, Masood R, Smith DL, Hinton DR, Kim CN, Fang G, Bhalla K, Gill PS. PMID: 18521433.
      View in: PubMed   Mentions:
    88. Expression of the human immunodeficiency virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma. Blood. 1999 Jul 01; 94(1):275-82. Kundu RK, Sangiorgi F, Wu LY, Pattengale PK, Hinton DR, Gill PS, Maxson R. PMID: 10381523.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    89. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol. 1999 Jun; 17(6):1876-83. Gill PS, Tulpule A, Espina BM, Cabriales S, Bresnahan J, Ilaw M, Louie S, Gustafson NF, Brown MA, Orcutt C, Winograd B, Scadden DT. PMID: 10561228.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    90. Antineoplastic urinary protein inhibits Kaposi's sarcoma and angiogenesis in vitro and in vivo. Blood. 1999 Feb 01; 93(3):1038-44. Masood R, McGarvey ME, Zheng T, Cai J, Arora N, Smith DL, Sloane N, Gill PS. PMID: 9920854.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    91. Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma. J Clin Oncol. 1998 Oct; 16(10):3369-74. Tulpule A, Yung RC, Wernz J, Espina BM, Myers A, Scadden DT, Cabriales S, Ilaw M, Boswell W, Gill PS. PMID: 9779714.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    92. Emerging treatments for epidemic (AIDS-related) Kaposi's sarcoma. Curr Opin Oncol. 1998 Sep; 10(5):413-21. McGarvey ME, Tulpule A, Cai J, Zheng T, Masood R, Espina B, Arora N, Smith DL, Gill PS. PMID: 9800111.
      View in: PubMed   Mentions: 2     Fields:    Translation:Cells
    93. Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc Natl Acad Sci U S A. 1998 Jul 07; 95(14):8257-61. Gill PS, Tsai YC, Rao AP, Spruck CH, Zheng T, Harrington WA, Cheung T, Nathwani B, Jones PA. PMID: 9653174.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    94. Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four cases. Oncol Nurs Forum. 1998 Jan-Feb; 25(1):67-70. Cabriales S, Bresnahan J, Testa D, Espina BM, Scadden DT, Ross M, Gill PS. PMID: 9460774.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    95. Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma. J Natl Cancer Inst. 1997 Dec 03; 89(23):1797-802. Gill PS, McLaughlin T, Espina BM, Tulpule A, Louie S, Lunardi-Iskandar Y, Gallo RC. PMID: 9392621.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    96. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma. Cancer J Sci Am. 1997 Sep-Oct; 3(5):278-83. Gill PS, Mitsuyasu RT, Montgomery T, Huang J, Cabriales S, Testa M, Espina BM, Levine AM, Miles SA. PMID: 9327151.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    97. Treatment of epidemic (AIDS-related) Kaposi's sarcoma. Curr Opin Oncol. 1997 Sep; 9(5):433-9. Jie C, Tulpule A, Zheng T, Masood R, Espina B, Gill PS. PMID: 9327221.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    98. Glucocorticoids induce Kaposi's sarcoma cell proliferation through the regulation of transforming growth factor-beta. Blood. 1997 Mar 01; 89(5):1491-500. Cai J, Zheng T, Lotz M, Zhang Y, Masood R, Gill P. PMID: 9057628.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    99. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci U S A. 1997 Feb 04; 94(3):979-84. Masood R, Cai J, Zheng T, Smith DL, Naidu Y, Gill PS. PMID: 9023368.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansAnimalsCells
    100. Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma. Ann Oncol. 1997 Jan; 8(1):79-83. Tulpule A, Joshi B, DeGuzman N, Espina BM, Mocharnuk R, Prakash O, Templeton D, Levine AM, Gill PS. PMID: 9093711.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    101. IL-4R expression in AIDS-KS cells and response to rhIL-4 and IL-4 toxin (DAB389-IL-4). Invest New Drugs. 1997; 15(4):279-87. Cai J, Zheng T, Murphy J, Waters CA, Lin GY, Gill PS. PMID: 9547670.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    102. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N Engl J Med. 1996 Oct 24; 335(17):1261-9. Gill PS, Lunardi-Ishkandar Y, Louie S, Tulpule A, Zheng T, Espina BM, Besnier JM, Hermans P, Levine AM, Bryant JL, Gallo RC. PMID: 8857005.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    103. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. J Clin Oncol. 1996 Aug; 14(8):2353-64. Gill PS, Wernz J, Scadden DT, Cohen P, Mukwaya GM, von Roenn JH, Jacobs M, Kempin S, Silverberg I, Gonzales G, Rarick MU, Myers AM, Shepherd F, Sawka C, Pike MC, Ross ME. PMID: 8708728.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCTClinical Trials
    104. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time. Cancer. 1996 Aug 01; 78(3):517-26. Levine AM, Tulpule A, Espina B, Boswell W, Buckley J, Rasheed S, Stain S, Parker J, Nathwani B, Gill PS. PMID: 8697399.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    105. Increased radiosensitivity of normal tissue fibroblasts in patients with acquired immunodeficiency syndrome (AIDS) and with Kaposi's sarcoma. Int J Radiat Biol. 1995 Oct; 68(4):411-2. Formenti SC, Chak L, Gill P, Buess EM, Hill CK. PMID: 7594966.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    106. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med. 1995 Jun 29; 332(26):1744-8. Gill PS, Harrington W, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA, Bernstein-Singer M, Espina BM, Cabral L, Allen S. PMID: 7760890.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCTClinical Trials
    107. Effects of interleukin-1 and interleukin-1 receptor antagonist in AIDS-Kaposi's sarcoma. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15; 8(5):455-60. Louie S, Cai J, Law R, Lin G, Lunardi-Iskandar Y, Jung B, Masood R, Gill P. PMID: 7697441.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    108. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol. 1995 Apr; 13(4):996-1003. Gill PS, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM. PMID: 7707129.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    109. Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma. AIDS. 1994 Dec; 8(12):1695-9. Gill PS, Miles SA, Mitsuyasu RT, Montgomery T, McCarthy S, Espina BM, Feldstein M, Levine AM. PMID: 7534090.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    110. An unusual case of metastatic intracardiac plasmacytoma. Can J Cardiol. 1994 Oct; 10(8):857-60. Tak T, Rashtian M, De Tar M, Chandraratna PA, Gill P. PMID: 7954022.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    111. Extramedullary plasmacytoma of the heart presenting as cardiac emergency. Review of literature. Am J Clin Oncol. 1994 Oct; 17(5):427-9. Keung YK, Lau S, Gill P. PMID: 8092116.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    112. Inhibition of AIDS-associated Kaposi's sarcoma cell growth by DAB389-interleukin 6. AIDS Res Hum Retroviruses. 1994 Aug; 10(8):969-75. Masood R, Lunardi-Iskandar Y, Jean LF, Murphy JR, Waters C, Gallo RC, Gill P. PMID: 7811548.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    113. IL-10 inhibits HIV-1 replication and is induced by tat. Biochem Biophys Res Commun. 1994 Jul 15; 202(1):374-83. Masood R, Lunardi-Iskandar Y, Moudgil T, Zhang Y, Law RE, Huang CL, Puri RK, Levine AM, Gill PS. PMID: 8037735.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    114. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am J Pathol. 1994 Jul; 145(1):74-9. Cai J, Gill PS, Masood R, Chandrasoma P, Jung B, Law RE, Radka SF. PMID: 8030759.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    115. Human T-cell lymphotropic virus type I-associated retinal lymphoma. A clinicopathologic report. Arch Ophthalmol. 1994 Jul; 112(7):954-9. Kumar SR, Gill PS, Wagner DG, Dugel PU, Moudgil T, Rao NA. PMID: 8031276.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    116. Relationship of serum levels of oncostatin M to AIDS-related and classic Kaposi's sarcoma. J Acquir Immune Defic Syndr (1988). 1994 Apr; 7(4):410-4. Hamilton AS, Radka SF, Bernstein L, Gill PS, Gonsalves M, Naemura JR, Ross RK. PMID: 7907664.
      View in: PubMed   Mentions:
    117. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study. Leukemia. 1994; 8 Suppl 3:S26-32. Gill PS, Espina BM, Moudgil T, Kidane S, Esplin JA, Tulpule A, Levine AM. PMID: 7808021.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    118. Solid tumor treatment workshop summary. Leukemia. 1994; 8 Suppl 3:S83-4. Gill PS, Parkinson D. PMID: 7808033.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    119. Potentiation of cytotoxicity of Kaposi's sarcoma related to immunodeficiency syndrome (AIDS) by liposome-encapsulated doxorubicin. AIDS Res Hum Retroviruses. 1993 Aug; 9(8):741-6. Masood R, Husain SR, Rahman A, Gill P. PMID: 8217343.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    120. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma. AIDS. 1992 Dec; 6(12):1477-81. Gill PS, Bernstein-Singer M, Espina BM, Rarick M, Magy F, Montgomery T, Berry MS, Levine A. PMID: 1283520.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    121. Treatment of ocular adnexal Kaposi's sarcoma in acquired immune deficiency syndrome. Ophthalmology. 1992 Jul; 99(7):1127-32. Dugel PU, Gill PS, Frangieh GT, Rao NA. PMID: 1495793.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    122. Treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma using bleomycin-containing combination chemotherapy regimens. Semin Oncol. 1992 Apr; 19(2 Suppl 5):32-6; discussion 36-7. Ireland-Gill A, Espina BM, Akil B, Gill PS. PMID: 1384142.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    123. Intravenous immunoglobulin in the treatment of human immunodeficiency virus-related thrombocytopenia. Am J Hematol. 1991 Dec; 38(4):261-6. Rarick MU, Montgomery T, Groshen S, Sullivan-Halley J, Jamin D, Mazumder A, Gill PS, Loureiro C, Levine AM. PMID: 1746533.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    124. Pathogenesis of HIV-related malignancies. Curr Opin Oncol. 1991 Oct; 3(5):867-71. Gill PS. PMID: 1751580.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    125. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. Semin Oncol. 1991 Oct; 18(5 Suppl 7):53-7. Gill PS. PMID: 1719642.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    126. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. Am J Med. 1991 Apr; 90(4):427-33. Gill PS, Rarick M, McCutchan JA, Slater L, Parker B, Muchmore E, Bernstein-Singer M, Akil B, Espina BM, Krailo M. PMID: 1707230.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    127. Serum erythropoietin titers in patients with human immunodeficiency virus (HIV) infection and anemia. J Acquir Immune Defic Syndr (1988). 1991; 4(6):593-7. Rarick MU, Loureiro C, Groshen S, Sullivan-Halley J, Gill PS, Bernstein-Singer M, Levine AM. PMID: 1673713.
      View in: PubMed   Mentions:
    128. Recent advances in AIDS-related Kaposi's sarcoma. Curr Opin Oncol. 1990 Dec; 2(6):1161-6. Gill PS, Naidu YM, Salahuddin SZ. PMID: 2099846.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    129. Interferon-alpha maintenance therapy after cytotoxic chemotherapy for treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Biol Response Mod. 1990 Oct; 9(5):512-6. Gill PS, Rarick MU, Bernstein-Singer M, Espina BM, Jones B, Montgomery T, Sharma D, Rasheed S, Levine AM. PMID: 2254762.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    130. The response of symptomatic gastrointestinal Kaposi's sarcoma to chemotherapy: a prospective evaluation using an endoscopic method of disease quantification. Am J Gastroenterol. 1990 Aug; 85(8):959-61. Laine L, Amerian J, Rarick M, Harb M, Gill PS. PMID: 1695812.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    131. Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine. Am J Clin Oncol. 1990 Aug; 13(4):315-9. Gill P, Rarick M, Bernstein-Singer M, Harb M, Espina BM, Shaw V, Levine A. PMID: 1696066.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    132. Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma. Results of pilot studies using combination chemotherapy. Cancer. 1990 Mar 01; 65(5):1074-8. Gill PS, Rarick MU, Espina B, Loureiro C, Bernstein-Singer M, Akil B, Levine AM. PMID: 1689209.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    133. Treatment of epidemic Kaposi's sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine. Ann Oncol. 1990; 1(2):147-9. Rarick MU, Gill PS, Montgomery T, Bernstein-Singer M, Jones B, Levine AM. PMID: 1706615.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    134. Human T-cell lymphotropic virus type I (HTLV-I)-associated adult T-cell leukemia-lymphoma in a patient infected with human immunodeficiency virus type 1 (HIV-1). Ann Intern Med. 1989 Dec 01; 111(11):871-5. Shibata D, Brynes RK, Rabinowitz A, Hanson CA, Slovak ML, Spira TJ, Gill P. PMID: 2573306.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    135. Recent advances in AIDS-related Kaposi's sarcoma. Curr Opin Oncol. 1989 Oct; 1(1):57-61. Gill PS, Brynes R. PMID: 2489949.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    136. Pulmonary Kaposi's sarcoma: clinical findings and results of therapy. Am J Med. 1989 Jul; 87(1):57-61. Gill PS, Akil B, Colletti P, Rarick M, Loureiro C, Bernstein-Singer M, Krailo M, Levine AM. PMID: 2472743.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    137. Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1989 Jun 01; 110(11):937-40. Gill PS, Loureiro C, Bernstein-Singer M, Rarick MU, Sattler F, Levine AM. PMID: 2719427.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    138. Primary central nervous system lymphoma in AIDS. Results of radiation therapy. Cancer. 1989 Mar 15; 63(6):1101-7. Formenti SC, Gill PS, Lean E, Rarick M, Meyer PR, Boswell W, Petrovich Z, Chak L, Levine AM. PMID: 2917314.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    139. Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma. Blood. 1989 Jan; 73(1):235-9. Adams JS, Fernandez M, Gacad MA, Gill PS, Endres DB, Rasheed S, Singer FR. PMID: 2910361.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    140. Protein A immunoadsorption therapy in HIV-related immune thrombocytopenia: a preliminary report. Artif Organs. 1988 Dec; 12(6):484-90. Bertram JH, Snyder HW, Gill PS, Shulman I, Henry DH, Jenkins D, Kiprov DD. PMID: 3063241.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    141. Production of a positive direct antiglobulin test due to suramin. Arch Pathol Lab Med. 1988 Sep; 112(9):898-900. Jamin D, Shulman I, Lam HT, Aguilar S, Shields M, Cohen J, Gill P, Levine A. PMID: 3415441.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    142. Autopsy findings in AIDS-related lymphoma. Cancer. 1988 Aug 15; 62(4):735-9. Loureiro C, Gill PS, Meyer PR, Rhodes R, Rarick MU, Levine AM. PMID: 3395957.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    143. Third-World Hodgkin's disease at Los Angeles County-University of Southern California Medical Center. J Clin Oncol. 1988 Aug; 6(8):1285-92. Hu E, Hufford S, Lukes R, Bernstein-Singer M, Sobel G, Gill P, Pinter-Brown L, Rarick M, Rosen P, Brynes R. PMID: 3411341.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    144. Radiation therapy for acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Clin Oncol. 1988 May; 6(5):863-7. Chak LY, Gill PS, Levine AM, Meyer PR, Anselmo JA, Petrovich Z. PMID: 3367189.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    145. HIV-related malignant lymphoma: clinical aspects, treatment, and pathogenesis. Cancer Invest. 1988; 6(4):413-6. Gill PS, Levine AM. PMID: 3179773.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    146. A comparison of imaging, clinical, and pathologic aspects of space-occupying lesions within the brain in patients with acquired immune deficiency syndrome. Am J Physiol Imaging. 1986; 1(3):134-41. Gill PS, Graham RA, Boswell W, Meyer P, Krailo M, Levine AM. PMID: 3451758.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    Parkash's Networks
    Concepts (647)
    Derived automatically from this person's publications.
    _
    Co-Authors (57)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _